Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 23

List of Figures
Figure No.
Figure Title
Page No.
Figure 221: AstraZeneca Revenue, By Segments, 2017(%) 239
Figure 222: AstraZeneca Revenue, By Region, 2017(%) 239
Figure 223: Boehringer-Ingelheim, Net Sales, 2013-2017 (USD Million) 241
Figure 224: Boehringer-Ingelheim, By Segments, 2017(%) 241
Figure 225: Boehringer-Ingelheim, By Region, 2017(%) 241
Figure 226: Teva Pharmaceuticals, Net Sales, 2013-2017 (USD Million) 243
Figure 227: Teva Pharmaceuticals, By Segments, 2017(%) 243
Figure 228: Teva Pharmaceuticals, By Region, 2017(%) 243
Figure 229: Chiesi Farmaceutici S.p.A. , Net Sales, 2013-2017 (USD Million) 245
Figure 230: Chiesi Farmaceutici S.p.A. , By Segments, 2017(%) 245
Figure 231: Chiesi Farmaceutici S.p.A. , By Segments, 2017(%) 245
Figure 232: Novartis, Net Sales, 2013-2017 (USD Million) 247
Figure 233: Novartis, Revenue, By Segment, 2017(%) 247
Figure 234: Novartis, Revenue, By Region, 2017(%) 247
Figure 235: Cipla, Net Sales, 2013-2017 (USD Million) 249
Figure 236: Cipla , By Region, 2017(%) 249
Figure 237: Mylan, Net Sales, 2013-2017 (USD Million) 251
Figure 238: Mylan, By Region, 2017(%) 251
Figure 239: Vectura Group , Net Sales, 2013-2017 (USD Million) 253
Figure 240: Vectura Group, By Products, 2017(%) 253
(c) AZOTH Analytics
23